国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

美國Watson Pharmaceuticals, Inc.
2006年 制藥廠(chǎng)商Watson Pharmaceuticals決定以大約19億美元收購Andrx，以壯大其非專(zhuān)利藥(generic drug)業(yè)務(wù)，在迅速整合的產(chǎn)業(yè)中與較大的對手并駕齊驅。

Watson表示，上述并購將使其成為美國第三大非專(zhuān)利藥廠(chǎng)商。它將以每股25美元的價(jià)格收購Andrx，較過(guò)去30天Andrx的平均股價(jià)溢價(jià)32%。預計上述交易將增加其2007年獲利。合并后的公司將擁有超過(guò)60項非專(zhuān)利藥的申請。Watson表示，預計今年將推出8種或更多新藥。

 
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets and distributes brand and generic pharmaceutical products. With one of the broadest product offerings in the U.S. generics industry and a track record of service excellence, Watson has earned a solid reputation as a reliable and low-cost provider of quality pharmaceutical products.